Written Q&A to EU Commission – Joint answer on trans fatty acids

In this answer to four written questions by MEPs (click the highlighted numbers to open them), Mr. Borg analyses the state of the art in EU about trans fatty acids. In US the issue is at the top of the FDA agenda. FDA has made a preliminary determination that partially hydrogenated oils (PHOs), the major … Continue reading Written Q&A to EU Commission – Joint answer on trans fatty acids